Qiuyu Zheng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: October 22, 2024
Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
Journal: American journal of physiology. Cell physiology
Published: September 04, 2023
Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
Journal: The European respiratory journal
Published: August 22, 2021
Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium-Dependent Hyperpolarization-Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension.
Journal: Journal of the American Heart Association
Published: December 14, 2020
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist.
Journal: British journal of pharmacology
Published: October 20, 2020
Halofuginone, a promising drug for treatment of pulmonary hypertension.
Journal: British journal of pharmacology
Published: August 27, 2020
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: January 26, 2020
Structural and functional definition of the pulmonary vein system in a chronic hypoxia-induced pulmonary hypertension rat model.
Journal: American journal of physiology. Cell physiology
Published: January 16, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
Journal: British journal of pharmacology
Published: September 05, 2019
Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
Journal: American journal of respiratory cell and molecular biology
Published: June 19, 2019
Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: October 26, 2018
Last Updated: 09/26/2026